iiinova — where your digital self keeps evolving

Ashlan J. Kunz Coyne @ashlan-kunz-coyne.bsky.social · 22/05/2026

Excited to share our new paper in JAC! Used 96h hollow fiber infection models with Stenotrophomonas maltophilia isolates to compare aztreonam/avibactam vs aztreonam+ceftazidime/avibactam. Assessed killing durability and blaL1/blaL2 expression. Thanks to the team! academic.oup.com/jac/article-...

academic.oup.com

Durability and mechanistic performance of aztreonam/avibactam versus aztreonam plus ceftazidime/avibactam against Stenotrophomonas maltophilia complex

AbstractBackground. Stenotrophomonas maltophilia complex infections are difficult to treat because of intrinsic resistance mediated by the L1 metallo-β-lac

011

Reposted by Ashlan J. Kunz Coyne

MidTN Antimicrobial Stewardship (MTAS) Symposium @mtassymposium.bsky.social · 17/02/2026

Join us for the 10th Annual Middle Tennessee Antimicrobial Stewardship Symposium this May in Nashville, TN! Accepted abstracts will receive a discount for registration. @pratishpatel.bsky.social @ashlan-kunz-coyne.bsky.social @athenalvhobbs.bsky.social @alainaann27.bsky.social

023

Reposted by Ashlan J. Kunz Coyne

MidTN Antimicrobial Stewardship (MTAS) Symposium @mtassymposium.bsky.social · 09/03/2026

Check out the lineup for the 10th Annual Middle TN Antimicrobial Stewardship Symposium! Poster submissions are open. www.belmont.edu/pharmacy-hea... @pratishpatel.bsky.social ky.social @ashlan-kunz-coyne.bsky.social @athenalvhobbs.bsky.social bbs.bsky.social @alainaann27.bsky.social bsky.social

032

Reposted by Ashlan J. Kunz Coyne

MidTN Antimicrobial Stewardship (MTAS) Symposium @mtassymposium.bsky.social · 19/03/2026

We're counting down the 10th MTAS with the top 10 reasons to attend! Join a great community & share research in the poster session (abstracts due 3/23) www.belmont.edu/pharmacy-hea... #antimicrobialstewardship @pratishpatel.bsky.social @athenalvhobbs.bsky.social @ashlan-kunz-coyne.bsky.social

034

Ashlan J. Kunz Coyne @ashlan-kunz-coyne.bsky.social · 28/09/2025

I'm thrilled to share our lab's new manuscript on molecular and pharmacodynamic insights into beta-lactam therapy for E. cloacae high inoculum infections! journals.asm.org/doi/10.1128/aa… Special thanks to the team and to @sidpharm.bsky.social for the generous funding and supporting my vision.

journals.asm.org

021

Reposted by Ashlan J. Kunz Coyne

Let’s Talk Micro @letstalkmicro.bsky.social · 15/08/2025

Happy Friday! 🎉 A new episode just dropped: ESBL, UTIs & new antibiotics 💊🦠 What’s new? 🎙️ Link in comments. #microbiology #podcast #ESBL #UTI #antibiotics @ashlan-kunz-coyne.bsky.social

271

Ashlan J. Kunz Coyne @ashlan-kunz-coyne.bsky.social · 09/08/2025

This publication is different. I began it 3 months postpartum, when my mind and body felt unfamiliar. Slowly, I found joy in writing again. Seeing it published as an Editor’s Choice is deeply meaningful. Grateful to the Kunz Coyne Lab for their support! academic.oup.com/ofid/article...

academic.oup.com

Propensity-Matched Comparison of Timely vs. Delayed Antibiotic Therapy in Stenotrophomonas maltophilia Pneumonia

AbstractBackground. Stenotrophomonas maltophilia, a multidrug-resistant nosocomial pathogen, is associated with high mortality and therapeutic challenges d

010

Reposted by Ashlan J. Kunz Coyne

ACCP ID PRN @accpinfdprn.bsky.social · 21/06/2025

Attending ASM Microbe? SIDP and ACCP ID PRN are co-hosting an ID Pharmacists and Friends Get Together! All pharmacists, friends, and trainees welcome! When: Saturday, June 21st, 2025 Where: Lazy Dog (Attendees will be responsible for own food/beverage)

131